Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 10, 2012, Pages 1365-1370

  Breton, Guillaume ^a   Bourgarit, A ^b   Pavy, S ^c   Bonnet, D ^d,e   Martinez, V ^f   Duval, X ^e   Longuet, P ^e   Abgrall, S ^g   Simon, A ^a   Leport, C ^h,i   Baakili, A ^j   Begle A M ^j   Bergmann, J F ^j   Besse, F ^j   Bollens, D ^j   Bouchaud, O ^j   Bursachi, P ^j   Cadranel, J ^j   Camuset, J ^j   Chakvetadze, C ^j   Courtial, S ^j   Delcey, V ^j   Delgado, J ^j   Diemer, M ^j   Dupont, B ^j   Elmarsafy, S ^j   Fain, O ^j   Fonquernie, L ^j   Furco, A ^j   Irard, P M G ^j   Grillot Courvalin, C ^j   Grivois, J F ^j   Guignet, A ^j   Guilleminot, M C ^j   Herrmann, J L ^j   Jeantils, V ^j   Joly, V ^j   Jouan, M ^j   Jouis, V ^j   Katlama, C ^j   Klutse, P ^j   Lacombe, K ^j   Lafaurie, M ^j   Lahoulou, R ^j   Lavole A ^j   Lefebvre, B ^j   Lefort, A ^j   Letellier, E ^j   Lortholary, O ^j   Metro, A ^j   Meynard, J L ^j   Meyohas, M C ^j   Molina, J M ^j   Obenga, G ^j   Parrinello, M ^j   Pelet, O ^j   Pialoux, G ^j   Pintado, C ^j   Ponscarme, D ^j   Rami, A ^j   Rozenbaum, W ^j   Sahli, H ^j   Samri, A ^j   Sellier, P ^j   Slama, L ^j   Stirnemann, J ^j   Tassi, S ^j   Taulera, O ^j   Touitou, H ^j   Trumeau, M ^j   Tubiana, R ^j   Vacher, I ^j   Vincent, F ^j   Yeni, P ^j   more..

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c BICÊTRE HOSPITAL   (France)

^d CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^e BICHAT HOSPITAL   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

^g AVICENNE HOSPITAL   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j NONE

more..

Author keywords

Antiretroviral interruption; Antiretroviral therapy; HIV; Immune reconstitution inflammatory syndrome; Steroids; Tuberculosis

Indexed keywords

EFAVIRENZ; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG USE; FEMALE; FRANCE; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT DURATION; TUBERCULOSIS; VIRUS REPLICATION; WATCHFUL WAITING;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS;

EID: 84866514935     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0693     Document Type: Article

References (19)

1. Shelburne S A, Hamill R J, Rodriguez-Barradas M C, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81: 213-227. (Pubitemid 34507208)
2. French M A, Price P, Stone S F. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18: 1615-1627. (Pubitemid 39095778)
3. Colebunders R, John L, Huyst V, Kambugu A, Scano F, Lynen L. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. Int J Tuberc Lung Dis 2006; 10: 946-953. (Pubitemid 44378968)
4. Breton G. Immune reconstitution inflammatory syndrome. In: Schaaf S H, Zumla A, eds. Tuberculosis: a comprehensive clinical reference. London, UK: Saunders Elsevier, 2009: 689-700.
5. Lawn S D, Myer L, Bekker L G, et al. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 2: 335-341. (Pubitemid 46175045)
6. Manabe Y C, Cambell J D, Sydnor E, et al. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46: 456-462. (Pubitemid 350098697)
7. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39: 1709-1712. (Pubitemid 39578550)
8. Blanc F X, Sok T, Laureillard D, et al. Significant enhancement in survival with early (52 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis [THLBB1]. Vienna, Austria: XVIII International AIDS Conference, 18-23 July 2010. [Abstract]
9. Havlir D, Ive P, Kendall M, et al. International randomized trial of immediate versus early ART in HIV patients treated for TB: ACTG 5221 STRIDE study. Boston, MA, USA: XVIII Conference on Retroviruses and Opportunistic Infections, 27 February-2 March 2011. [Abstract No. 38]
10. Abdool-Karim S S, Naidoo K, Padayatchi N, et al. Optimal timing of ART during TB therapy: finding of the SAPiT trial. Boston, MA, USA: XVIII Conference on Retroviruses and Opportunistic Infections, 27 February-2 March 2011. [Abstract 39LB]
11. Kaplan J E, Benson C, Homes K K, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Recomm Rep 2009; 58 (RR04): 1-198.
12. Lesho E. Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome. Expert Rev Anti Infect Ther 2006; 4: 469-478. (Pubitemid 43905468)
13. Meintjes G, Wilkison R J, Morroni C, et al. Randomized p lacebo-controlled trial of prednisone for paradoxical tuberculosis immune reconstitution inflammatory syndrome. AIDS 2010; 24: 2381-2390.
14. Meintjes G, Lawn S D, Maartens G, et al. International network for the study of HIV-associated IRIS. Tuberculosisa ssociated immune reconstitution inflammatory syndrome: case definition for use in resource-limited settings. Lancet Infect Dis 2008; 8: 516-523. (Pubitemid 352005824)
15. Bourgarit A, Carcelain G, Samri A, et al. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gamma delta T cells. J Immunol 2009; 183: 3915-3923.
16. Huyst V, Lynen L, Bottieau E, Zolfo M, Kestens L, Colebunders R. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin Belg 2007; 62: 126-129. (Pubitemid 46724411)
17. Park W B, Choe P G, Jo J H, et al. Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long-term outcome. AIDS 2006; 20: 2390-2392. (Pubitemid 44789544)
18. Müller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 251-261.
19. Pepper D J, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009; 48: e96-e107.